PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Genetics Branch, Center for Cancer Research, National Cancer Institute, 37 Convent Dr. MSC 4265, Bldg 37, Rm 6040, Bethesda, MD, 20892, USA.\', \'Protein Expression Laboratory, NCI RAS Initiative, Frederick National Laboratory for Cancer Research, Frederick, MD, USA.\', \'Codex BioSolutions, Inc, Gaithersburg, MD, USA.\', \'Lipoprotein Metabolism Section, National Heat, Lung, and Blood Institute, Bethesda, MD, USA.\', \'Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD, USA.\', \'Genetics Branch, Center for Cancer Research, National Cancer Institute, 37 Convent Dr. MSC 4265, Bldg 37, Rm 6040, Bethesda, MD, 20892, USA. caoli@mail.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41598-022-06629-2
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 35173254
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
is ?:relation_isRelatedTo_publication of
?:title
  • mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all